FASTKD2 and breast carcinoma: In our studies, expression of NRIF3/DD1 leads to a rapid 3- to 7-fold increase in FASTKD2 expression within 5–8 h in breast cancer cell lines [5] as well as in LNCaP cells (Figure 4B and 4C).